Drug Profile

Research programme: cachexia and anorexia therapeutics - Obexia

Alternative Names: 1E8a scFv; OBX 1201; OBX 1202

Latest Information Update: 28 Apr 2018

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes
Available For Licensing Yes

28 Apr 2018 No recent reports of development identified for preclinical development in Anorexia in Switzerland (IV)
28 Apr 2018 No recent reports of development identified for preclinical development in Cachexia in Switzerland (IV)
26 Sep 2016 Research programme: cachexia and anorexia therapeutics - Obexia is available for licensing as of 26 Sep 2016. http://obexia.com/about.php

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com